Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Sep;71(3):266–271. doi: 10.1136/adc.71.3.266

Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study.

D A Price 1, D I Johnston 1, P R Betts 1, J M Buckler 1, M D Donaldson 1
PMCID: PMC1029987  PMID: 7979506

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchanan C. R., Preece M. A., Milner R. D. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991 Apr 6;302(6780):824–828. doi: 10.1136/bmj.302.6780.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clayton P. E., Shalet S. M., Gattamaneni H. R., Price D. A. Does growth hormone cause relapse of brain tumours? Lancet. 1987 Mar 28;1(8535):711–713. doi: 10.1016/s0140-6736(87)90355-2. [DOI] [PubMed] [Google Scholar]
  3. Leukaemia in patients treated with growth hormone. Lancet. 1988 May 21;1(8595):1159–1160. [PubMed] [Google Scholar]
  4. Martin L. G., Clark J. W., Connor T. B. Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab. 1968 Mar;28(3):425–428. doi: 10.1210/jcem-28-3-425. [DOI] [PubMed] [Google Scholar]
  5. Milner R. D., Burns E. C. Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee. Arch Dis Child. 1982 Dec;57(12):944–947. doi: 10.1136/adc.57.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Milner R. D., Russell-Fraser T., Brook C. G., Cotes P. M., Farquhar J. W., Parkin J. M., Preece M. A., Snodgrass G. J., Mason A. S., Tanner J. M. Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) 1979 Jul;11(1):15–38. doi: 10.1111/j.1365-2265.1979.tb03043.x. [DOI] [PubMed] [Google Scholar]
  7. Penny R., Blizzard R. M. The possible influence of puberty on the release of growth hormone in three males with apparent isolated growth hormone deficiency. J Clin Endocrinol Metab. 1972 Jan;34(1):82–84. doi: 10.1210/jcem-34-1-82. [DOI] [PubMed] [Google Scholar]
  8. Ranke M. B., Guilbaud O., Lindberg A., Cole T. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl. 1993 Sep;82 (Suppl 391):82–89. doi: 10.1111/j.1651-2227.1993.tb12936.x. [DOI] [PubMed] [Google Scholar]
  9. Ranke M. B. The Kabi Pharmacia International Growth Study: aetiology classification list with comments. Acta Paediatr Scand Suppl. 1991;379:87–92. doi: 10.1111/j.1651-2227.1991.tb12052.x. [DOI] [PubMed] [Google Scholar]
  10. Rosenfeld R. G., Northcraft G. B., Hintz R. L. A prospective, randomized study of testosterone treatment of constitutional delay of growth and development in male adolescents. Pediatrics. 1982 Jun;69(6):681–687. [PubMed] [Google Scholar]
  11. Stanhope R., Brook C. G. Oxandrolone in low dose for constitutional delay of growth and puberty in boys. Arch Dis Child. 1985 Apr;60(4):379–381. doi: 10.1136/adc.60.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES